Apellis Pharmaceuticals, Inc.
APLSDelisted May 14, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492422
Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Apellis Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 187
- +8 vs. Q3 2021
- Shares held
- 81.0M
- +11.5M (+16.6%) vs. Q3 2021
- Total value
- $3.83B
- +$1.54B (+67.1%) vs. Q3 2021
- New holders
- 44
- 73 more added
- Sold out
- 36
- 53 more reduced
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $10.2K |
| Q1 2026 | 324 | $5.56B |
| Q4 2025 | 280 | $3.17B |
| Q3 2025 | 273 | $2.77B |
| Q2 2025 | 247 | $2.28B |
| Q1 2025 | 255 | $2.80B |
| Q4 2024 | 260 | $4.04B |
| Q3 2024 | 265 | $3.41B |
| Q2 2024 | 263 | $4.43B |
| Q1 2024 | 302 | $6.65B |
| Q4 2023 | 284 | $6.82B |
| Q3 2023 | 256 | $4.34B |
| Q2 2023 | 317 | $9.71B |
| Q1 2023 | 282 | $7.28B |
| Q4 2022 | 244 | $5.20B |
| Q3 2022 | 250 | $6.66B |
| Q2 2022 | 212 | $4.15B |
| Q1 2022 | 212 | $4.62B |
| Q4 2021 | 187 | $3.83B |
| Q3 2021 | 181 | $2.29B |
| Q2 2021 | 205 | $4.08B |
| Q1 2021 | 175 | $2.80B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Apellis Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cowen and Company, LLC | 0 | $0 | 0.00% | −57,889−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −40,966−100.0% | Sold out |
| Palisade Capital Management LLC | 0 | $0 | 0.00% | −35,583−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −35,264−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −34,671−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −33,143−100.0% | Sold out |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −26,458−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −23,300−100.0% | Sold out |
| Ipswich Investment Management Co., Inc. | 0 | $0 | 0.00% | −22,265−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −19,763−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −13,991−100.0% | Sold out |
| Sippican Capital Advisors | 0 | $0 | 0.00% | −6,513−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −3,497−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −3,006−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −2,628−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,100−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,990−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −1,236−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −276−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| First Mercantile Trust Co | – | – | – | – | Not filed |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |